Influvac Tetra Description

Influenza virus surface antigens (inactivated) (haemagglutinin and neuraminidase) of the following strains*: A/Victoria/2570/2019 (H1N1)pdm09-like strain (A/Victoria/2570/2019, IVR-215) 15 micrograms HA **, A/Darwin/9/2021 (H3N2)-like strain (A/Darwin/9/2021, SAN-010) 15 micrograms HA **, B/Austria/1359417/2021-like strain (B/Austria/1359417/2021, BVR-26) 15 micrograms HA **, B/Phuket/3073/2013-like strain (B/Phuket/3073/2013, wild type) 15 micrograms HA ** per 0.5 ml dose.
* propagated in fertilized hens' eggs from healthy chicken flocks.
** haemagglutinin.
This vaccine complies with the World Health Organization (WHO) recommendation (northern hemisphere) and EU recommendation for the 2022/2023 season.
Influvac Tetra may contain traces of eggs (such as ovalbumin, chicken proteins), formaldehyde, cetyltrimethylammonium bromide, polysorbate 80 or gentamicin, which are used during the manufacturing process (see Contraindications).
Excipients/Inactive Ingredients: Potassium chloride, potassium dihydrogen phosphate, disodium phosphate dihydrate, sodium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate and water for injections.